
AbCellera Biologics
Unlocking the power of natural immunity to discover antibody therapies501-1000 EmployeesActively Hiring
- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
AbCellera Biologics Funding
$519.3M
11 round
AbCellera Biologics is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $519.3M. Their most recent funding was raised on May 24, 2023.
Funding Rounds
S
$519259259